ENAVATE SCIENCES GP, LLC: UPB position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of ENAVATE SCIENCES GP, LLC on UPB, newest first. How the timeline and the estimate are built.
ENAVATE SCIENCES GP, LLC held 2,459,703 UPB shares at 2026-06-30 per its 13F-HR filed 2026-08-14.
the latest 13F is the newest step
- period ended2026-06-3013F 2,459,703 sharesChange vs previous 13F 0 shares
4.93% of the 13F portfolio, value $17,021,145.
13F-HR 0001953107-26-000012 filed by ENAVATE SCIENCES GP, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2026-03-3113F 2,459,703 sharesChange vs previous 13F 0 shares
6.3% of the 13F portfolio, value $22,137,327.
13F-HR 0001953107-26-000008 filed by ENAVATE SCIENCES GP, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-12-3113F 2,459,703 sharesChange vs previous 13F 0 shares
13.18% of the 13F portfolio, value $66,780,936.
13F-HR 0001953107-26-000003 filed by ENAVATE SCIENCES GP, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-09-3013F 2,459,703 sharesChange vs previous 13F 0 shares
14.13% of the 13F portfolio, value $46,267,013.
13F-HR 0001953107-25-000014 filed by ENAVATE SCIENCES GP, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-06-3013F 2,459,703 sharesChange vs previous 13F 0 shares
15.3% of the 13F portfolio, value $27,007,539.
13F-HR 0001415889-25-021852 filed by ENAVATE SCIENCES GP, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-03-3113F 2,459,703 sharesChange vs previous 13F 0 shares
11.34% of the 13F portfolio, value $15,053,382.
13F-HR 0001415889-25-013132 filed by ENAVATE SCIENCES GP, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2024-12-3113F 2,459,703 sharesChange vs previous 13F not available
29.04% of the 13F portfolio, value $40,437,517.
13F-HR 0001104659-25-014094 filed by ENAVATE SCIENCES GP, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).